Outcomes in 886 Critically Ill Patients After Near-Hanging Injury.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
12 2020
Historique:
received: 24 01 2020
revised: 15 06 2020
accepted: 03 07 2020
pubmed: 8 8 2020
medline: 27 5 2021
entrez: 8 8 2020
Statut: ppublish

Résumé

Near-hanging experiences are life-threatening events about which few data are available. What are the outcomes and early predictors of hospital mortality in critically ill patients who have undergone a near-hanging experience? Adult patients who were resuscitated successfully after suicidal near-hanging injury admitted to 31 university or university-affiliated ICUs in France and Belgium between 1992 and 2014 were studied retrospectively. Patients were identified by searching the hospital databases for International Statistical Classification of Diseases and Related Health Problems, 9th and 10th revisions, codes and hospital charts for hanging. Logistic multivariate regression was performed to identify factors associated vital and functional outcomes at hospital discharge as the primary end points. Secondary outcomes were evaluation of temporal trends and identification of predictors of hospital mortality. Of the 886 patients (181 women and 705 men; median age, 43 years; interquartile range, 34-52 years), 266 (30.0%) had attempted suicide previously, 600 (67.7%) had a diagnosed mental illness, and 55 (6.2%) attempted hanging while hospitalized. Median time from hanging awareness to unhanging was 0 min (interquartile range [IQR], 0-0; range, 0-82 min). Median Glasgow Coma Scale score was 3 (IQR, 3-5) at ICU admission. Hanging induced cardiac arrest in 450 of 886 patients (50.8%). Overall, 497 of 886 patients (56.1%) were alive at hospital discharge, including 479 of 497 patients (96.4%) with a favorable neurocognitive outcome (defined as a Glasgow Outcome Scale score of 4 or 5). By multivariate analysis, factors associated with hospital mortality were hanging-induced cardiac arrest (OR, 19.50; 95% CI, 7.21-60.90; P < .00001) and findings at ICU admission of glycemia level > 1.4 g/L (OR, 4.34; 95% CI, 1.82-10.81; P = .0007) and of lactate level > 3.5 mmol/L (OR, 9.98; 95% CI, 4.17-25.36; P < .00001). The findings from this large multicenter retrospective cohort emphasize the very high mortality after hanging injury chiefly because of hanging-induced cardiac arrest. However, patients who survive near-hanging experiences achieve excellent neurocognitive recovery. Studies of early neuroprotective strategies for patients who have undergone near-hanging experiences are warranted. ClinicalTrials.gov; No.: NCT04096976; URL: www.clinicaltrials.gov.

Sections du résumé

BACKGROUND
Near-hanging experiences are life-threatening events about which few data are available.
RESEARCH QUESTION
What are the outcomes and early predictors of hospital mortality in critically ill patients who have undergone a near-hanging experience?
STUDY DESIGN AND METHODS
Adult patients who were resuscitated successfully after suicidal near-hanging injury admitted to 31 university or university-affiliated ICUs in France and Belgium between 1992 and 2014 were studied retrospectively. Patients were identified by searching the hospital databases for International Statistical Classification of Diseases and Related Health Problems, 9th and 10th revisions, codes and hospital charts for hanging. Logistic multivariate regression was performed to identify factors associated vital and functional outcomes at hospital discharge as the primary end points. Secondary outcomes were evaluation of temporal trends and identification of predictors of hospital mortality.
RESULTS
Of the 886 patients (181 women and 705 men; median age, 43 years; interquartile range, 34-52 years), 266 (30.0%) had attempted suicide previously, 600 (67.7%) had a diagnosed mental illness, and 55 (6.2%) attempted hanging while hospitalized. Median time from hanging awareness to unhanging was 0 min (interquartile range [IQR], 0-0; range, 0-82 min). Median Glasgow Coma Scale score was 3 (IQR, 3-5) at ICU admission. Hanging induced cardiac arrest in 450 of 886 patients (50.8%). Overall, 497 of 886 patients (56.1%) were alive at hospital discharge, including 479 of 497 patients (96.4%) with a favorable neurocognitive outcome (defined as a Glasgow Outcome Scale score of 4 or 5). By multivariate analysis, factors associated with hospital mortality were hanging-induced cardiac arrest (OR, 19.50; 95% CI, 7.21-60.90; P < .00001) and findings at ICU admission of glycemia level > 1.4 g/L (OR, 4.34; 95% CI, 1.82-10.81; P = .0007) and of lactate level > 3.5 mmol/L (OR, 9.98; 95% CI, 4.17-25.36; P < .00001).
INTERPRETATION
The findings from this large multicenter retrospective cohort emphasize the very high mortality after hanging injury chiefly because of hanging-induced cardiac arrest. However, patients who survive near-hanging experiences achieve excellent neurocognitive recovery. Studies of early neuroprotective strategies for patients who have undergone near-hanging experiences are warranted.
TRIAL REGISTRY
ClinicalTrials.gov; No.: NCT04096976; URL: www.clinicaltrials.gov.

Identifiants

pubmed: 32758563
pii: S0012-3692(20)32091-2
doi: 10.1016/j.chest.2020.07.064
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04096976']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2404-2413

Investigateurs

Nicolas Girard (N)
Martin Cour (M)
Adriaan Prisacariu (A)
Auguste Dargent (A)
Ferhat Meziani (F)
Thibaut Baudic (T)
Philippe Vignon (P)
Candice Belony (C)
Charlene Leparq (C)
Cecile Carre (C)
Pauline Moriss (P)
Emmanuelle Noel (E)
Sebastien Cavelot (S)
Delphine Bachelet (D)
Quentin De Roux (Q)
Matthieu Resche-Rigon (M)
Christophe Guitton (C)
Bruno Megarbane (B)
Charles Cerf (C)
Alexandre Demoule (A)
Pierre Kalfon (P)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Louise de Charentenay (L)

Medical-Surgical Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France.

Guillaume Schnell (G)

Medical-Surgical Intensive Care Unit, GH Le Havre, Le Havre, France.

Nicolas Pichon (N)

Medical-Surgical Intensive Care Unit, CHU de Limoges, Limoges, France; AfterROSC, Paris, France.

Maleka Schenck (M)

Medical Intensive Care Unit, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Pierrick Cronier (P)

AfterROSC, Paris, France; Intensive Care Unit, Sud-Francilien Hospital Center, Corbeil-Essonnes, France.

Sebastien Perbet (S)

Department of Perioperative Medicine, University Hospital of Clermont-Ferrand, Université Clermont Auvergne, CNRS, Inserm, GReD, Clermont-Ferrand, France.

Jean-Baptiste Lascarrou (JB)

AfterROSC, Paris, France; INSERM U970, Paris Cardiovascular Research Center, Paris, France; Medicine Intensive Reanimation, University Hospital, Nantes, France.

Thomas Rossignol (T)

Medical-Surgical Intensive Care Unit, Centre Hospitalier du Mans, Le Mans, France.

Olivier Lesieur (O)

AfterROSC, Paris, France; Intensive Care Unit, Saint-Louis Hospital, La Rochelle, France.

Laurent Argaud (L)

AfterROSC, Paris, France; Medical Intensive Care Unit, Hospices Civils de Lyon, Edouard Herriot Teaching Hospital, Lyon, France.

Gwenhael Colin (G)

AfterROSC, Paris, France; Medical-Surgical Intensive Care Unit, La Roche-sur-Yon District Hospital Center, La Roche-sur-Yon, France.

Bernard Cholley (B)

Service de Réanimation Chirurgicale, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.

Jean-Pierre Quenot (JP)

Service de Médecine Intensive-Réanimation, CHU Dijon Bourgogne, France.

Hamid Merdji (H)

Service de Médecine Intensive Réanimation, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Faculté de Médecine and Translationnelle de Strasbourg (FMTS), Université de Strasbourg (UNISTRA), Strasbourg, France; UMR 1260, Regenerative Nano Medecine, INSERM, Fédération de Médecine, Strasbourg, France.

Stein Silva (S)

AfterROSC, Paris, France; Réanimation Polyvalente, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Michael Piagnerelli (M)

Intensive Care Unit, Marie-Curie Teaching Hospital, Charleroi, Belgium.

Jonathan Chelly (J)

AfterROSC, Paris, France; Intensive Care Unit, Groupe Hospitalier Sud Ile de France, Melun, France.

Marie Salvetti (M)

Medical-Surgical Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France.

Segolene Couraud (S)

Medical-Surgical Intensive Care Unit, GH Le Havre, Le Havre, France.

Nicolas Deye (N)

AfterROSC, Paris, France; Medical Intensive Care Unit, Lariboisière Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Marc Danguy des Déserts (M)

Clermont Tonnerre Military Hospital, Brest, France.

Marine Paul (M)

Medical-Surgical Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France.

Guillaume Thiery (G)

Medical-Surgical Intensive Care Unit, Saint-Etienne University Hospital, Saint-Etienne, France.

Marc Simon (M)

Intensive Care Department, Cliniques du Sud-Luxembourg of Arlon, Arlon, Belgium.

Charlotte Martin (C)

Anesthésie Réanimation, Hôpital Purpan, CHU Toulouse, Toulouse, France.

François Vincent (F)

Medical-Surgical Intensive Care Unit, Avicenne University Hospital, Bobigny, France.

Vincent Das (V)

Medical-Surgical Intensive Care Unit, Centre Hospitalier Intercommunal André Grégoire, Montreuil, France.

Gwenaelle Jacq (G)

Medical-Surgical Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France.

Frederic Jacobs (F)

Medical Intensive Care Unit, Beclere Teaching Hospital, Clamart, France.

Alexis Soummer (A)

Department of Intensive Care Medecine, Foch Hospital, Suresnes, France.

Julien Mayaux (J)

Department of Pneumology and Intensive Care, Pitie Salpetriere Teaching Hospital, Paris, France.

Pascal Beuret (P)

Department of Intensive and Continuous Care, Roanne Hospital, Roanne, France.

Abdelkader Ouchenir (A)

Medical Intensive Care Unit, Louis Pasteur Hospital, Chartres, France.

Caroline Durant (C)

Intensive Care Unit, Marie-Curie Teaching Hospital, Charleroi, Belgium.

Mickael Darmon (M)

Medical Intensive Care Unit, Saint Louis Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Elie Azoulay (E)

Medical Intensive Care Unit, Saint Louis Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Bertrand Sauneuf (B)

AfterROSC, Paris, France; General Intensive Care Unit, Cotentin Public Hospital Center, Cherbourg-en-Cotentin, France.

Cedric Daubin (C)

AfterROSC, Paris, France; Medical Intensive Care Unit, Caen Teaching Hospital, Caen, France.

Nicolas Mongardon (N)

AfterROSC, Paris, France; Department of Anesthesiology and Surgical Intensive Care Units, Henri Mondor Teaching Hospital, Créteil, France.

Lucie Biard (L)

Service de Biostatistique et Information Médicale, AP-HP Hôpital Saint Louis, Paris, France; Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments (ECSTRRA) Team, INSERM U1153 CRESS, Paris, France.

Alain Cariou (A)

AfterROSC, Paris, France; INSERM U970, Paris Cardiovascular Research Center, Paris, France; Medical Intensive Care Unit, Cochin Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Thomas Geeraerts (T)

Anesthésie Réanimation, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Stephane Legriel (S)

Medical-Surgical Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France; AfterROSC, Paris, France; Team PsyDev, CESP, INSERM, UVSQ, University Paris-Saclay, Villejuif, France. Electronic address: slegriel@ch-versailles.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH